Member Info for Saint68

Personally I would like hear what the problems are when they receive the letter and what they are doing to resolve the issues. This may provide a small boost to the current SP.

That’s what the filter option is used for - so that you don’t have to scroll through all the tripe posted by the usual suspects.

What was your previous moniker Whymeagainffs ? Previously banned and back to cause disruption again is my guess.

Well said Lenoman - your thoughts echo mine.

HH - I hope you take your own advice and follow through on your statement below. I won’t expect any further interaction between you and the 5 posters below. Your mental health will benefit, as will the BB. You’re one of the good guys here and I’d hate to see you go because of those muppets.

“I think the best thing we can all do is FILTER him, One2One, Pumpky, CJ Sterling and Tuan for starters. That way, like minded shareholders can interact without sifting through all the predictable rubbish from the de-rampers.”

Ok and thanks for the reply. Looking forward to hearing what Vlad has to say and whether he’ll be able to give an idea of timeframe.

Spot on about Toffers Jamesp21 - she's got many aliases on here and Twitter and is an absolute fruit loop. Currently on EUA and apparently threatening legal action against the BOD - I've filtered so cannot see the drivel.

HH - have you had confirmation that Vlad's interview is tomorrow ?

"We will find out tomorrow why the FDA placed CAR-T on hold and what Hemo have to do to overcome it"

Totally agree pwlx. I will not support that either. They've told us things are very difficult at present and I guess divulging too much information could have a negative impact. They do not want to bring unwanted attention upon the company and riding out the storm is fine by me.

Don't think Vlad is Russian Dhub. Israeli I think.

Sorry to see you go HH. If you come back do as I and many others do - filter them on day 1. You know who talks nonsense and tries to disrupt so why give them the satisfaction of a reply. If nobody replies they’ll eventually go away. Good luck to you and hopefully see you back when the good news starts to flow.

Uk was never in line to be buying from us. As advised via RNS we're dealing with BRICS countries.

HH - "Phase 1 is a relatively low cost trial and take 'month' not years." this is not completely accurate as some Phase 1 do take years. Avacta are currently around 640 days into Phase 1a. Each trial is different and we don't know how long phase 1 will take here. Below is a link to a February 2021 update.

https://avacta.com/phase-i-clinical-trial-authorisation-for-ava6000-approved-by-mhra/

Another nice update Jaygee - thanks.

Agreed Del. I have IKN in the bin for continually engaging and making the board unreadable. It's a shame as some f his posts are good.

Absolutely agree BoB and anyone who interacts with them is just clogging the board with tripe. Best to ignore and they'll f..k off eventually.

Another one out of the assylum - binned.

JHFH - similar situation to yourself as in I only took a quick glance at Autolus as I don't the time to go more in depth at present.

HH - yes we seem pretty aligned. I would think we'll see a move up to maybe 4 - 5p on confirmation that IND has been approved and maybe another small tick up when the 1st patient has been dosed. The bigger increases will come at various points throughout P1 and again at the end of a successful (hopefully) P1.

Ok let’s wait until we are clinical then compare again. Including companies like Gilead, Juno, Allogene and Fate on there is like comparing your local corner shop with Tesco.

I’ve taken a very quick look at Autolus and they’re much further ahead -“ Obe-cel phase 2 pivotal FELIX clinical trial met its primary endpoint at an interim analysis in 2022 with additional data expected in mid-2023.”

If we get through phase 1 I would expect us to be many multiples higher than where we sit today. Not long to wait before we can start that journey 👍

Nice work JHFH but I feel some of those comparisons are not a like for like comparison with HEMO. We currently have no products in clinical trials while many of the companies listed are well established and have other products much further down the line. I agree that way are way undervalued but let’s keep it real when comparing.